Winthrop Pharmaceuticals UK Ltd

One Onslow Street, Guildford, Surrey, GU1 4YS, UK
Telephone: +44 (0)1483 505 515
Fax: +44 (0)1483 554 831
E-mail: UK-medicalinformation@sanofi-aventis.com
Medical Information Direct Line: +44 (0)1483 554 101
Medical Information Fax: +44 (0)1483 554 831

Summary of Product Characteristics last updated on the eMC: 29/01/2010
SPC Gentamicin Intrathecal 5mg/ml Solution for Injection

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 29/01/2010 and displayed until Current
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
  • Change to section 8 - MARKETING AUTHORISATION NUMBER(S)
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   01-Dec-2009
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

The MAH has changed from Aventis (Roussel) to Winthrop Pharmaceuticals
Updated on 09/09/2009 and displayed until 29/01/2010
Reasons for adding or updating:
  • Change to section 9 - Date of first Authorisation/renewal of the Authorisation
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   03-Mar-2009
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Changes to dates in Section 9 and 10 due to renewal of licence
Updated on 30/08/2005 and displayed until 09/09/2009
Reasons for adding or updating:
  • Change from BAN to rINN
  • Change to section 10 (date of (partial) revision of the text
Updated on 03/06/2004 and displayed until 30/08/2005
Reasons for adding or updating:
  • New SPC for new product

Active Ingredients/Generics

 
   gentamicin sulphate